Ginkgo Bioworks Holdings (DNA) Treasury Shares (2019 - 2026)

Ginkgo Bioworks Holdings' Treasury Shares history runs 8 years deep, the most recent figure standing at $3.0 million for Q1 2026.

• Quarterly Treasury Shares fell 26.71% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (down 26.71% YoY) and the FY2025 annual result came in at $4.4 million, up 32.45% from the prior year.
• Treasury Shares was $3.0 million for Q1 2026 at Ginkgo Bioworks Holdings, down from $4.4 million in the prior quarter.
• Across five years, Treasury Shares topped out at $238.7 million in Q1 2024 and bottomed at $564227.0 in Q4 2023.
• A 5-year average of $89.3 million and a median of $23.5 million in 2022 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2023 — Treasury Shares surged 615.15% — and 2025, when it tumbled 98.28%.
• Ginkgo Bioworks Holdings' Treasury Shares stood at $23.5 million in 2022, then slumped by 97.6% to $564227.0 in 2023, then soared by 489.73% to $3.3 million in 2024, then surged by 32.45% to $4.4 million in 2025, then plunged by 31.56% to $3.0 million in 2026.
• Business Quant data shows DNA's Treasury Shares at $3.0 million in Q1 2026, $4.4 million in Q4 2025, and $4.7 million in Q3 2025.